In a groundbreaking move that underscores their commitment to democratizing access to clinical research, Headlands Research, a global network of 17 clinical trial sites, has announced the acquisition of Clinical Research Professionals, a well-established site situated in the bustling metropolitan area of St. Louis, Missouri. This strategic merger brings together decades of collective expertise and the collaboration of accomplished principal investigators (PIs) across diverse therapeutic domains.
At the heart of this acquisition lies Headlands Research‘s visionary goal of making clinical research accessible to a wider demographic. In expressing his commitment, the CEO of Headlands Research, Kyle Burtnett, emphasizes their vision to make clinical research accessible to all individuals. With the assimilation of Clinical Research Professionals, Headlands not only extends its participant outreach but also gains a mature research center with seasoned leadership. This expansion positions Headlands to support an increased number of clinical trials, enhancing participant recruitment efforts and facilitating access to investigational therapies across a spectrum of medical indications.
Doug Grasse, CEO of Clinical Research Professionals, emphasizes their dedication to collaboration with innovative organizations and professionals in the pursuit of advancing medical therapies. Grasse emphasized their dedication to collaboration with innovative organizations, physicians, and clinical research professionals in order to improve lives through the advancement of medical therapies. The integration with Headlands Research provides Clinical Research Professionals access to state-of-the-art platform capabilities, amplifying their collaborative opportunities to better serve the community.
The acquisition of Clinical Research Professionals follows closely on the heels of Headlands Research’s recent incorporation of AMCR Institute into its portfolio. In addition, Headlands Research has expanded its footprint with the launch of a new clinical research site and the acquisition of two well-established sites: Headlands Research Detroit, specializing in therapeutic areas such as Alzheimer’s disease and vaccines, and Headlands Research Eastern Massachusetts, focused on neurodegenerative diseases like Alzheimer’s. Clinvest Research, another addition, specializes in chronic diseases, including migraine and arthritis.
As Headlands Research continues to solidify its position as a leader in clinical research, the acquisition of Clinical Research Professionals stands as a pivotal move. This strategic expansion not only broadens the network’s capabilities but also fortifies its commitment to inclusivity in medical research. By fostering collaborations, embracing seasoned professionals, and strategically acquiring established sites, Headlands Research is propelling the frontier of clinical research, promising a future where medical advancements are within reach for a diverse and representative population.
Headlands Research, a distinguished multinational integrated clinical trial site organization, stands as a beacon in the pursuit of advancing innovative medical therapies with a profound commitment to improving lives. Comprising a consortium of outstanding sites, the organization specializes in large-volume recruitment, targeting both diverse and specialty patient populations while consistently delivering data of the utmost quality. At the core of Headlands Research’s success are its principal investigators, acknowledged industry leaders with a diverse range of expertise across various medical indications.
With a proven track record that boasts the completion of over 5,000 clinical trials, Headlands Research distinguishes itself through a commitment to excellence in participant care, research conduct, and data delivery. Their approach is characterized by expert recruitment strategies, leveraging site databases, and cultivating robust physician partnerships to ensure access to diverse patient pools.
A hallmark of the company is its unwavering dedication to compassionate and empathetic practices. This ethos extends to participants, team members, and research partners, creating an inclusive environment built on principles of respect, understanding, and support. Integrity is the cornerstone of their operations, with a commitment to transparency, clear communication, and the setting of precise expectations to establish and fortify trust with both participants and partners.
At Headlands Research, the participant is unequivocally at the center of their focus. This is reflected in their personalized approach to interactions, acknowledging each participant as a unique individual and tailoring every engagement to provide a bespoke and unparalleled experience. Through these principles and practices, Headlands Research maintains its pledge to produce optimal outcomes for participants, ensuring that their contributions to clinical research are valued and respected.
For those seeking more information about Headlands Research, a comprehensive overview is available at www.headlandsresearch.com.
Clinical Research Professionals (CRP) emerges as a privately owned and dedicated research center, positioning itself as a key player in the realm of clinical research trials. Functioning as a collaborative network, CRP orchestrates the efforts of physicians and a team of research professionals with a shared goal of advancing new drug therapies and medical devices, ultimately contributing to the improvement of lives.
Central to CRP’s operations is its strategic partnership with pharmaceutical companies and physicians, facilitating the enrollment of clinical trials across a diverse array of therapeutic areas. The focal point of these endeavors is CRP’s impressive 10,000-square-foot research and vaccine center, serving as the hub for managing and overseeing clinical trials.
CRP’s strength lies in its extensive volunteer participant database, boasting a remarkable 35,000 individuals. This vast pool of volunteers underscores the organization’s capacity to conduct trials across various therapeutic domains with a diverse and representative participant base.
Dedication to the management of clinical research trials is a cornerstone of CRP’s mission, underscored by an unwavering commitment to integrity and professionalism. This commitment is not just a tagline but a guiding principle that shapes every aspect of their operations.
Within the medical expertise realm, CRP hosts a distinguished roster of physicians specializing in crucial areas, including Alzheimer’s Dementia, Endocrinology/Obesity/Diabetes/Metabolic Syndrome, Gastroenterology, Internal Medicine/Family Medicine, Neurology, Parkinson’s disease, Pain, Spine, Rehab/Physiatry, Respiratory/Pulmonary, Women’s Health, and Men’s Health.
Check out CRP’s Official Website to learn more.
Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CpE
An eTMF system offers multiple operational advantages over traditional paper-based TMFs.
viral respiratory infections are among the most urgent concerns, especially when it comes to young children.
Despite advances, key gaps in understanding insulin resistance persist, including CNS diagnostics, brain-periphery interactions, and apoE isoform roles, highlighting critical research priorities for new treatments.
GAS1’s discovery represents a beacon of hope in the fight against metastatic disease.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings